NCT07821671Not yet recruiting
Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study
Source: ClinicalTrials.gov · Last updated 16 Sept 2026
Brief summary (registry, in English)
This study uses a rapid randomized controlled trial (RCT) design to examine HIV pre-exposure prophylaxis (PrEP) delivered through telehealth. This study will develop a knowledge base of small, effective changes to digital messaging and website design to improve telemedicine PrEP (telePrEP) provision for MISTR users in the United States.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 223165 (estimated)
- First submitted
- 9 Sept 2026
- Start date
- Mar 2027
- Primary completion date
- May 2031
- Lead sponsor
- Emory University
- Diseases
- HIV
- NCT number
- NCT07821671
What you commit to
- Study type: Interventional
- Planned participants: 223165
- From Mar 2027 to the primary completion date, May 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Individuals who do not use MISTR services
- Individuals who do not reside in the United States
Who the study is looking for
- Adults aged \>= 18 years
- Individuals who use MISTR services
- Reside in the United States
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Emory University Rollins School of Public Health Coordinator of this site? Confirm its status | Atlanta | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.